According to global media, Novartis is discussing options with banks for selling its near $14-billion stake in rival Roche, potentially providing cash for new deals. Novartis built up its one-third stake in Roche’s voting stock between 2001 and 2003 under former chairman and CEO Daniel Vasella, as thebasis for a possible merger that never happened. Shares of Novartis India will also remain in focus, though the deal may not materialise immediately.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.